Neuroblastoma: Treatment outcome after incomplete resection of primary tumors

Pediatric Surgery International

Volumn 25, Issue 9, 2009, Pages 789-793

  Moon, Suk Bae ^a,b   Park, Kwi Won ^a   Jung, Sung Eun ^a   Youn, Woong Jae ^a  

^a Seoul National University   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Incomplete excision; Interleukin 2; Neuroblastoma; Retinoic acid; Stem cell transplantation

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; ISOTRETINOIN; MELPHALAN; RECOMBINANT INTERLEUKIN 2; THIOTEPA; TOPOTECAN;

ARTICLE; CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; MALE; MEDICAL RECORD REVIEW; MYELOABLATIVE CONDITIONING; NEUROBLASTOMA; ONCOGENE C MYB; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT REFUSAL;

ADRENAL GLAND NEOPLASMS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; FEMALE; FOLLOW-UP STUDIES; GENES, MYC; HUMANS; INFANT; INTERLEUKIN-2; ISOTRETINOIN; MALE; MEDIASTINAL NEOPLASMS; NEOPLASM, RESIDUAL; NEUROBLASTOMA; PELVIC NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RADIOTHERAPY, ADJUVANT; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 69549133499     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-009-2417-8     Document Type: Article

References (19)

1. Grosfeld JL (2006) Neuroblastoma. In: Grosfeld JL, O'Neill JA, Fonkalsrud EW, Coran AG (eds) Pediatric surgery, 6th edn. Mosby, St. Louis, pp 467-494
2. KK Matthay C Perez RC Seeger, et al. 1998 Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study J Clin Oncol 16 1256 1264
3. ES Adkins R Sawin RB Gerbing, et al. 2004 Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study J Pediatr Surg 39 931 936
4. J Michon B De Bernardi H Rubie, et al. 2000 Surgery as the only treatment for INSS stage 2 neuroblastoma: risk factors predicting relapse Med Pediatr Oncol 35 758
5. MP La Quaglia BH Kushner W Su, et al. 2004 The impact of gross total resection on local control and survival in high-risk neuroblastoma J Pediatr Surg 39 412 417
6. DO Stram KK Matthay M O'Leary, et al. 1996 Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies J Clin Oncol 14 2417 2426
7. EM Kiely 1993 Radical surgery for abdominal neuroblastoma Semin Surg Oncol 9 489 492
8. CP Reynolds KK Matthay JG Villablanca, et al. 2003 Retinoid therapy of high-risk neuroblastoma Cancer Lett 197 185 192
9. KK Matthay JG Villablanca RC Seeger, et al. 1999 Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis retinoic acid N Engl J Med 341 1165 1173
10. KH Ryu HS Ahn HH Koo, et al. 2003 Autologous stem cell transplantation for the treatment of neuroblastoma in Korea J Korean Med Sci 18 242 247
11. HN Lode R Xiang T Dreier, et al. 1998 Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy Blood 91 1706 1715
12. P Vivancos A Granena 1999 Treatment with interleukin-2 (IL-2) and interferon after autologous bone marrow or peripheral blood stem cell transplantation in onco-hematological malignancies with a high risk of relapse Bone Marrow Transplant 23 169 172
13. R Ladenstein T Phillip C Lasset, et al. 1998 Multivariate analysis of risk factors for stage 4 neuroblastoma over the age of one year treated with mega therapy and stem cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry J Clin Oncol 16 953 965
14. RE George S Li C Medeiros-Nancarrow D Neuberg, et al. 2006 High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update J Clin Oncol 20 2891 2896
15. KK Matthay CP Reynolds RC Seeger, et al. 2009 Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study J Clin Oncol 27 1007 1013
16. R Handgretinger J Greil U Schürmann, et al. 1997 Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma J Hematother 6 235 242
17. HN Lode R Handgretinger U Schuermann, et al. 1997 Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry Eur J Cancer 33 2024 2030
18. R Häfer A Voigt B Gruhn, et al. 1999 Neuroblastoma cells can express the hematopoietic progenitor cell antigen CD34 as detected at surface protein and mRNA level J Neuroimmunol 96 201 206
19. V Castel JA Tovar E Costa, et al. 2002 The role of surgery in stage IV neuroblastoma J Pediatr Surg 37 1574 1578